Kevin Lobo

Director

Kevin Lobo (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in GE HealthCare Technologies Inc. (GEHC). Across 1 priced purchase filing, the average 21-session return was -0.9% from execution and +1.0% from disclosure (delay-adjusted; derived). The largest single filing was $642K of GEHC (10,000 sh × $64.18, as filed), executed May 22.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

-0.9%

avg across 1 priced filings

Delay-adjustediThe same average, entered at disclosure dates

+1.0%

same 1 filings, from disclosure

Filings, ttm

1 buys · 0 sells

Median delay

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$642K

shares × price, as filed

Last traded

May 22

Filed May 26

Median ADV $965.3M across their filed names

Open performance→

Volume by month

Buys $642K Sells $21.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

GEHC

GE HealthCare Technologies Inc. GEHC · 1 buy · 0 sells 1 filing SYK

Stryker Corporation SYK · 0 buys · 1 sell 1 filing

Recent filings

GEHCPURCHASE GE HealthCare Technologies Inc. View filing → $642K
10,000 sh × $64.18
Exec May 22
Filed May 26 · 6:44 PM ET SYKSALE Stryker Corporation View filing → $21.1M
57,313 sh across 3 lots
Exec Nov 7 2024
Filed Nov 8 2024 · 5:30 PM ET